EGFR and non-small cell lung carcinoma: In addition, NRI, SIRI, ALI, CONUT, LMR, NLR, PNI, and SII could predict the response of NSCLC patients to EGFR-TKI (P < 0.05), except for PLR (P > 0.05) (Figure S6A–I).